FDA authorizes marketing of Zika IgM test
by Press Release from Outbreak News Today on (#4FRJZ)
Today, the U.S. Food and Drug Administration authorized marketing of a diagnostic test to detect Zika virus immunoglobulin (IgM) antibodies in human blood. The ZIKV Detect 2.0 IgM Capture ELISA is the first Zika diagnostic test the FDA has allowed to be marketed in the U.S.; previously, tests for detecting Zika virus IgM antibodies-including the ZIKV Detect 2.0 IgM ["]
The post FDA authorizes marketing of Zika IgM test appeared first on Outbreak News Today.